27
Views
12
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

Antimicrobial Resistance of Respiratory Pathogens in North African Countries

Pages 627-632 | Published online: 18 Jul 2013

REFERENCES

  • Bartlett JG, Breiman RF, Mandell LA, File TM. community acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26 (4): 811–38.
  • Tibazarwa KB, Volmink JA, Mayosi BM. The incidence of acute rheumatic fever in the world: a systematic review of popu-lation-based studies. Heart 2008: 94 (12): 1534–40.
  • Alpuche C, Garau J, Lim V. Global and local variations in antimicrobial susceptibilities and resistance development in the major respiratory pathogens. Int J Antimicrob Agents 2007; 30 Suppl 2: 5135–8.
  • Felmingham D, Feldman C, Hryniewicz W, Klugman K, Kohno S, Low DE, et al. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Mi-crobiol Infect 2002; 8 Suppl 2: 12–42.
  • Borg MA, Scicluna E, De Kraker M, van de Sande-Bruisma N, Tiermersma E, Gtir D et al. Antibiotic resistance in the south-eastern Mediterranean-preliminary results for the ARMed proj-ect. Euro Surveill 2006; 11 (7): 164–167.
  • Ramdani-Bouguessa N, RahalK. Serotype distribution and antimicrobial resistance and of S. pneumoniae isolated in Al-giers, Algeria. Antimicrob Agents Chemother 2003; 47: 824–826.
  • Benbachir M, Benredjeb S, Boye CS, Dosso M, Belabbes H, Kamoun A, et al. Two-year surveillance of antibiotic resist-ance in Streptococcus pneumoniae in four African cities. An-timicrob Agents Chemother 2001; 45: 627–9.
  • Rachdi M, Boutiba-Ben Boubaker I, Moatla S, Smaoui H, Hammami A, Kechrid A, et al. Phenotypic and genotypic char-acterization of macrolide resistant Streptococcus pneumoniae in Tunisia. Pathol Biol 2008; 56 (3): 125–9.
  • Soriano F, Cafini F, Aguilar L, Tarrago D, Alou L, Gimenez MJ, et al. Breackthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness. J An-timicrob Chemother 2008; 62 (6): 1234–40.
  • Jacobs MR, Felmingham D, Appelbaum PC, Grtineberg RN and the Alexander Project Group. The Alexander Project 1998-2000 : susceptibility of pathogens isolated from community -acquired respiratory tract infection to commonly used an-timicrobial agents. J Antimicrob Agents 2003; 52: 229–246.
  • Schito GC, Felingham D. Susceptibility of Streptococcus pneumoniae to penicillin, azythromycin and telithromycin (PRO-TEKT1999-2003). Int J Antimicrob Agents 2005; 26: 479485.
  • Schrag SJ, McGree L, Whitney CG, Bell B, Craig AS, Choate ME et al. Emergence of Streptococcus pneumoniae with very high level resistance to penicillin. Antimicrob Agents Chemother 2004; 48: 3016–3023.
  • Reinert RR, Ringelstein A, van der Linden M, Cil MY, Al-Lahham A, Schmitz FJ. Molecular epidemiology of macrolide resistant Streptococcus pneumoniae isolates in Europe. J Clin Microbiol 2005; 43: 1294–1300.
  • Drugeon H, Juvin M.E, Janus C. Antibacterial resistance among Streptococcus pneumoniae isolated in Europe, Turkey, Middle East, Africa and Asia (eBASKET2). Program and abstracts of the 44th Interscience Conference of Antimicrobial Agents and Chemotherapy; October 30-November 2, 2004; Washington, DC. Abstract C2-832.
  • Medeiros AA, O'Brien. Ampicillin resistant haemophilus influenzae type B possessing a TEM betalactamase but little per-meability barrier to ampicillin. Lancet 1975; i:716–719.
  • Tristram SG, Harwes R, Souprounov Y. Variation in se-lected regions of bleTEM gens and promoters in Haemophilus influenzae. J. Antimicrob Chemother 2005; 56: 481–484.
  • Hasegawa K, Chiba N, Koboryaski R, Muramaya SY, lwata S, Dunakawa K, et al. Rapidly increasing prevalence of beta-lactamase non producing ampicillin resistant Haemophilus influenzae type B with meningitis. Antimicrob Agents Chemother 2004; 48: 1509–1514.
  • Amabile-Cuevas CF, Hermida-Escobedo C, Vivar R. Com-parative in vitro activity of moxifloxacin by E-test against Strep-tococcus pyogenes. Clin Infect Dis 2001; 32 (1) : 30–2.
  • Capoor MR, Nair D, Deb M, Batra K, Aggarwal P. Resistance to erythromycin and rising penicillin MIC in Strepto-coccus pyogenes in India. Jpn J Infect Dis 2006; 59 :334–336.
  • Mazzariol A, Koncan R, Vitali LA, Cornaglia G. Activity of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resis-tant Streptococcus pyogenes and Streptococcus pneumoniae. J Antimicrob Chemother 2007; 59 :1171–1176.
  • Bassetti M, Manno E, CoIlia A, Ferrando A, Gatti G, Ugolotti E, et al. Erythromycin resistance in Streptococcus pyo-genes in Italy. Emerg Infect Dis 2000; 6 :180–3.
  • Pérez-Trallero E, Fernandez-Mazarrasa C, Garcia-Rey C, Souza E, Aguilar L, Garcia-de-Lomas J et al. Antimicrobial sus-ceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relation-ships: results of a 1-year (1998-1999) multicenter surveillaance study in Spain. Antimicrob Agents Chemother 2001; 45 (12) : 3334-40.
  • Malhotra-Kumar S, Lammens C, Chapelle S, Mallentjer C, Weyler J, Goossens H. Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes. J Antimicrob Chemother 2005 ; 55 (3).
  • Orscheln RC, Johnson DR, Olson SM, Presti RM, Mar-tin JM, Kaplan EL et al. Intrinsic reduced susceptibility of sero-type 6 Streptococcus pyogenes to fluoroquinolone antibiotics. J Infect Dis 2005; 191 (8) : 1272-79.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.